Sort
23,748 grants matching “melanoma”
SBIR Phase I: Highly Specific Flex-Hinge Antibody-Like Checkpoint Inhibitors for Safer and More Effective Cancer Therapy
$224,455Daniel J Capon · Hinge Bio, Inc. · · FY2018 · TIP
Special Public T Cell Receptor Sequences that Predict Outcomes for Cancer Patients
$224,400Seth M Pollack · Northwestern University At Chicago · R21 · FY2023 · CA
Strategies to improve the adoptive transfer of T cells
$224,371Stanley R Riddell · Fred Hutchinson Cancer Research Center · R01 · FY2010 · CA
Analytic and Clinical Validation of a 7-plex MIF Assay for Predictive Response of Advanced NSCLC to Anti-PD-1 based Therapy
$224,347Janis M. Taube · Johns Hopkins University · UH2 · FY2022 · CA
Project 3: Translational Studies and Clinical Pharmacology of TLR4 and TOPK Signaling Pathway Inhibitors for Prevention of Squamous Cell Carcinoma of the Skin
$224,173Clara Curiel-Lewandrowski · University Of Arizona · P01 · FY2022 · CA
LONG-CIRCULATING TUMOR-SELECTIVE DNA DELIVERY SYSTEMS
$224,153Northeastern University · R01 · FY2004 · CA
Protection Against Chemotherapy-Induced Gastrointestinal Mucositis by a Sphingosi
$224,116Charles D Smith · Apogee Biotechnology Corporation · R43 · FY2014 · DK
The Unfolded Protein Response in Melanoma Progression and Chemoresistance
$224,100Maria S Soengas · Spanish National Cancer Center · R01 · FY2012 · CA
The Unfolded Protein Response in Melanoma Progression and Chemoresistance
$224,100Maria S Soengas · Spanish National Cancer Center · R01 · FY2009 · CA
The Unfolded Protein Response in Melanoma Progression and Chemoresistance
$224,100Maria S Soengas · Spanish National Cancer Center · R01 · FY2008 · CA
The Unfolded Protein Response in Melanoma Progression and Chemoresistance
$224,100Maria S Soengas · Spanish National Cancer Center · R01 · FY2010 · CA
Mesenchymal Stromal Cells and Stromal Fibroblasts in Radiotherapy Resistance
$224,099Guangwen Ren · Jackson Laboratory · R00 · FY2018 · CA
Breast cancer Vaccine Strategies for HER2-Overexpressing and Lum. B Tumors
$224,073Jonathan Stuart Serody · Univ Of North Carolina Chapel Hill · P50 · FY2008 · CA
Specification, induction and development of the neural crest in rabbit embryos
$224,064Martin Ignacio Garcia-Castro · University Of California Riverside · R21 · FY2018 · DE
Early Clinical Testing for Melanin Targeting Radio-therapeutic agent in melanoma
$223,985John W Babich · Molecular Insight Pharmaceuticals, Inc. · R44 · FY2009 · CA
SOUTHWEST ONCOLOGY GROUP
$223,972University Of Michigan At Ann Arbor · U10 · FY2002 · CA
Analysis of Glycomic Regulators in Melanoma Progression
$223,942Charles J Dimitroff · Brigham And Women'S Hospital · U01 · FY2019 · CA
Development of genome-modified Xiphophorus
$223,927Manfred Schartl · Texas State University · R21 · FY2022 · OD
Tumor microvesicle-mediated modulation of the bone microenvironment
$223,901Evan Todd Keller · University Of Michigan At Ann Arbor · P01 · FY2019 · CA
In Vivo Imaging Facility
$223,866Jessie Nedrow · University Of Pittsburgh At Pittsburgh · P30 · FY2021 · CA
PEPTIDE VACCINES WITH/WITHOUT GMCSF IN STAGE IV MELANOMA
$223,864University Of Pittsburgh At Pittsburgh · R01 · FY2004 · CA
Highly Multiplexed Analysis of Solid Tumors and Liquid Tissues by Cyclic Immunofluorescence
$223,840Eric Kaldjian · Rarecyte, Inc. · R41 · FY2018 · CA
Breast cancer Vaccine Strategies for HER2-Overexpressing and Lum. B Tumors
$223,827Jonathan Stuart Serody · Univ Of North Carolina Chapel Hill · P50 · FY2009 · CA
Melanoma suppressing functions of carcinoma oncogene FOXQ1
$223,808Anna Bianchi-Smiraglia · Roswell Park Cancer Institute Corp · R21 · FY2017 · CA
Statistical Methods for Analyzing Antigen Receptors Data
$223,808Grzegorz A Rempala · Augusta University · R01 · FY2010 · CA